Nuwellis, Inc. (NUWE) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NUWE Revenue Growth
NUWE Revenue Analysis (2014–2025)
As of May 8, 2026, Nuwellis, Inc. (NUWE) generated trailing twelve-month (TTM) revenue of $8.3 million, reflecting modest growth of +4.4% year-over-year. The most recent quarter (Q4 2025) recorded $2.4 million in revenue, up 9.3% sequentially.
Looking at the longer-term picture, NUWE's 5-year compound annual growth rate (CAGR) stands at +2.1%, indicating moderate growth over time. The company achieved its highest annual revenue of $8.9 million in 2023.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), ANGO (+7.3% YoY), and ATRC (+15.0% YoY), NUWE has underperformed the peer group in terms of revenue growth. Compare NUWE vs NVCR →
NUWE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NUWECurrent | $8M | +4.4% | +2.1% | -134.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 CNMD | $1.4B | +4.4% | +9.8% | 10.3% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% |
NUWE Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $8.3M | -5.4% | $5.1M | 62.0% | $-11,106,000 | -134.3% |
| 2024 | $8.7M | -1.4% | $5.8M | 66.7% | $-10,988,000 | -125.7% |
| 2023 | $8.9M | +3.8% | $5.0M | 56.2% | $-17,630,000 | -198.9% |
| 2022 | $8.5M | +7.9% | $4.8M | 55.7% | $-17,171,000 | -201.0% |
| 2021 | $7.9M | +6.5% | $4.5M | 56.7% | $-19,526,000 | -246.5% |
| 2020 | $7.4M | +35.0% | $4.1M | 54.5% | $-17,028,000 | -228.8% |
| 2019 | $5.5M | +10.3% | $2.9M | 51.7% | $-18,106,000 | -328.5% |
| 2018 | $5.0M | +40.7% | $1.3M | 26.6% | $-17,036,000 | -340.9% |
| 2017 | $3.6M | +175.6% | $790K | 22.2% | $-14,812,000 | -416.9% |
| 2016 | $1.3M | +2084.7% | $576K | 44.7% | $-15,662,000 | -1215.1% |
See NUWE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NUWE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NUWE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNUWE — Frequently Asked Questions
Quick answers to the most common questions about buying NUWE stock.
Is NUWE's revenue growth accelerating or slowing?
NUWE revenue growth slowed to +4.4%, below the 5-year CAGR of +2.1%. TTM revenue is $8M. The deceleration marks a shift from historical growth rates.
What is NUWE's long-term revenue growth rate?
Nuwellis, Inc.'s 5-year revenue CAGR of +2.1% reflects the variable expansion pattern. Current YoY growth of +4.4% is near this long-term average.
How is NUWE's revenue distributed by segment?
NUWE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.